Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control von Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-labe... von Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Doherty, RP, Marshall, JL, Puig, IC, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM, TB042 Study Team

Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial von Abaasa, A, Egesa, M, Driciru, E, Koopman, JPR, Kiyemba, R, Sanya, RE, Nassuuna, J, Ssali, A, Kimbugwe, G, Wajja, A, van Dam, GJ, Corstjens, PLAM, Cose, S, Seeley, J, Kamuya, D, Webb, EL, Yazdanbakhsh, M, Kaleebu, P, Siddiqui, AA, Kabatereine, N, Tukahebwa, E, Roestenberg, M, Elliott, AM